Dianthus Therapeutics To Participate in the 8th Annual Evercore Healthcare Conference

Core Viewpoint - Dianthus Therapeutics, Inc. is actively participating in the 8th Annual Evercore Healthcare Conference, indicating its commitment to engaging with investors and showcasing its developments in the biotechnology sector focused on severe autoimmune diseases [1]. Company Overview - Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company based in New York City and Waltham, Massachusetts, dedicated to developing next-generation therapies for severe autoimmune diseases [3]. - The company is led by an experienced team of biotech and pharmaceutical executives aiming to deliver transformative medicines for patients suffering from severe autoimmune and inflammatory diseases [3]. Event Participation - CEO Marino Garcia will participate in a fireside chat on December 2, 2025, at 2:35 p.m. ET, and will also host one-on-one meetings with investors during the conference [1]. - A webcast of the presentation will be available under the "News and Events" section of the Dianthus Therapeutics website [2].